BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis (Q24317553)

negative regulation of reactive oxygen species metabolic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Krishna K Singh

1

0 references

Praphulla C Shukla

2

0 references

Adrian Quan

3

0 references

Mohammed Al-Omran

4

0 references

Fina Lovren

5

0 references

Yi Pan

6

0 references

Christine Brezden-Masley

7

0 references

Alistair J Ingram

8

0 references

William L Stanford

9

0 references

Hwee Teoh

10

0 references

Subodh Verma

The Journal of Thoracic and Cardiovascular Surgery

11

0 references

language of work or name

English

0 references

publication date

October 2013

0 references

published in

0 references

volume

146

0 references

issue

4

0 references

page(s)

949-960.e4

0 references

cites work

Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA1 down-regulates cellular levels of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

3,3'-Diindolylmethane decreases VCAM-1 expression and alleviates experimental colitis via a BRCA1-dependent antioxidant pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Oxidative stress and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Developmental studies of Brca1 and Brca2 knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA1 is an essential regulator of heart function and survival following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

SNPs in BRAP associated with risk of myocardial infarction in Asian populations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

BRCA2 variants and cardiovascular disease in a multi-ethnic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

1 reference

7 January 2021

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021

NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTCVS.2012.12.064

7 January 2021